Xact Kapitalforvaltning’s Sage Therapeutics SAGE Stock Holding History

Xact Kapitalforvaltning’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$234K	Hold	8,144	–	–	0.01%	1143
2019 Q4	$588K	Hold	8,144	–	–	0.01%	874
2019 Q3	$1.14M	Hold	8,144	–	–	0.02%	528
2019 Q2	$1.49M	Buy	8,144 +1,000	+14%	+$171K	0.03%	442
2019 Q1	$1.14M	Sell	7,144 -900	-11%	-$130K	0.03%	536
2018 Q4	$771K	Buy	8,044 +900	+13%	+$103K	0.02%	651
2018 Q3	$1.01M	Buy	7,144 +300	+4%	+$46.3K	0.02%	582
2018 Q2	$1.07M	Buy	6,844 +800	+13%	+$126K	0.02%	564
2018 Q1	$974K	Buy	6,044 +2,400	+66%	+$407K	0.02%	569
2017 Q4	$600K	Buy	+3,644	New	+$353K	0.01%	632

Other funds holding SAGE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Xact Kapitalforvaltning's SAGE Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Sage Therapeutics (SAGE) position steady in Q1 2020 at 8,144 shares worth $234K. The position accounts for 0.01% of the portfolio, ranked #1143.

Xact Kapitalforvaltning first reported a position in SAGE in Q4 2017 and has held it in 10 quarters since. The position peaked at $1.49M in Q2 2019. 230 funds tracked by Wall St. Rank hold SAGE as of Q1 2020.

Xact Kapitalforvaltning held 8,144 shares of Sage Therapeutics worth $234K as of Q1 2020.
Xact Kapitalforvaltning left its Sage Therapeutics share count unchanged in Q1 2020.
Sage Therapeutics made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #1143 holding.
Xact Kapitalforvaltning first reported a position in Sage Therapeutics in Q4 2017 and has held it in 10 quarters since.
Xact Kapitalforvaltning's Sage Therapeutics position peaked at $1.49M in Q2 2019.
230 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.